Conference Reports for NATAP
HIV Drug Therapy Glasgow 2024
10-13 November
Back
 
Tweet
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real- world OncoVIHAC ANRS CO24 cohort study